Asia Pacific Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Asia Pacific Wound Closure Devices Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Other Products), Wound Type (Chronic Wound and Acute Wound), and End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Other End Users)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Status : Published
  • Report Code : TIPRE00041361
  • Category : Life Sciences
  • No. of Pages : 171
  • Available Report Formats : pdf-format excel-format
Asia Pacific Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Oct 2025   |   Report Code: TIPRE00041361
Buy Now
Page Updated: Dec 2025

The Asia Pacific wound closure device market size is expected to reach US$ 3,555.76 million by 2031 from US$ 2,343.83 million in 2024. The market is estimated to record a CAGR of 6.3% from 2025-2031.

Executive Summary and Asia Pacific Wound Closure Device Market Analysis:

The Asia Pacific wound closure devices market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The rising innovations in wound care products and growing initiatives by public organizations largely drive market growth. Countries such as Thailand, India, and Singapore are becoming hubs for medical tourism, contributing to the demand for advanced surgical tools, including wound closure devices. With an increasing number of surgeries and chronic conditions such as diabetes and cardiovascular diseases in the region, the demand for these devices is soaring.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Asia Pacific Wound Closure Devices Market: Strategic Insights

asia-pacific-wound-closure-device-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia Pacific Wound Closure Device Market Segmentation Analysis:

Key segments that contributed to the derivation of the wound closure device market analysis are procuct, wound type, and end use.

  • By product, the wound closure device market is segmented into sutures, adhesives, staplers, strips, and others. The sutures held the largest share of the market in 2024.
  • By wound type, the wound closure device market is bifurcated into chronic wound and acute wound. The chronic wound held a larger share of the market in 2024.
  • By end use, the wound closure device market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals held the largest share of the market in 2024.

Asia Pacific Wound Closure Devices Market Report Scope

Report Attribute Details
Market size in 2024 US$ 2,343.83 Million
Market Size by 2031 US$ 3,555.76 Million
CAGR (2025 - 2031) 6.3%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Sutures
  • Staplers
  • Adhesives
  • Strips
  • Others
By Wound Type
  • Chronic Wound
  • Acute Wound
By End Use
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
Regions and Countries Covered Asia Pacific
  • Australia
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
Market leaders and key company profiles
  • B Braun SE
  • Johnson & Johnson
  • Medtronic Plc
  • 3M Co
  • Stryker Corp
  • Baxter International Inc
  • Meril Life Sciences Pvt Ltd
  • CooperSurgical, Inc
  • Smith & Nephew Plc
  • TI Medical
  • Futura Surgicare Pvt Ltd (Dolphin Sutures)
  • Corza Medical GmbH
  • Essity AB
  • Advanced Medical Solutions Group plc
  • Healthium Medtech Limited

Asia Pacific Wound Closure Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific Wound Closure Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

asia-pacific-wound-closure-device-market-cagr

Asia Pacific Wound Closure Device Market Outlook

Noncommunicable diseases (NCDs) or chronic diseases, such as heart disease, stroke, cancer, diabetes, and chronic lung disease, account for 74% of all deaths worldwide. Over three-quarters of NCD-related deaths, and 86% of the 17 million people who die before reaching 70 years of age, occur in low- and middle-income countries.

The growing number of chronic diseases, including diabetes and cardiovascular diseases, is a major opportunity for the wound closure devices market. Chronic diseases tend to cause complications that may necessitate surgeries or prolonged wound care. For instance, diabetic patients are likely to develop chronic wounds, including diabetic ulcers, which require appropriate care and closure devices for healing. The number of people living with diabetes rose by 830 million in 2022 from 200 million in 1990. The prevalence is growing more rapidly in low- and middle-income nations compared to high-income countries.

Moreover, the increasing number of trauma cases such as burns, accidents, and injuries is fueling the increased demand for effective wound care solutions. Trauma is a major global health issue, resulting in approximately 5.8 million deaths and 40 million permanent injuries each year. Nearly 90% of these fatalities occur in low- and middle-income countries. Common causes of trauma include road traffic accidents, falls, workplace injuries, and violence. This issue disproportionately affects younger populations and imposes a crucial economic burden due to lost productivity and healthcare costs.

Wound closure devices are needed to treat these conditions, providing quicker healing, minimizing infection risk, and enhancing overall patient outcomes. With a growing population of older people who are more susceptible to chronic conditions and a rise in the incidence of trauma cases, healthcare professionals prefer sophisticated wound closure solutions to meet these demands. The synergy between technological innovation, including the creation of specialized wound care products, and the demand for quicker recovery solutions creates a significant growth opportunity for the market. Producers that emphasize innovations specific to chronic wounds and trauma will likely account for a greater percentage of the market since the demand for successful wound treatment will keep growing around the world.

Asia Pacific Wound Closure Device Market Country Insights

Based on country, the Asia Pacific wound closure device market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2024.

The wound closure devices market in China is expanding due to the country's high manufacturing and export capabilities. According to the Institute for Health Metrics and Evaluation (IHME), road injuries are the fifth leading cause of death, and diabetes ranks ninth. Road injuries may cause chronic wounds requiring wound care in the long term. China has a high prevalence of diabetes, which is propelling the demand for wound care management to reduce the risk of slow-healing wounds in diabetic patients. Ulceration of the foot in diabetes is common and disabling, and frequently leads to amputation of the leg, thereby increasing the demand for diabetic foot care management. In 2021, the International Diabetes Federation (IDF) reported that the number of diabetic cases reported in China in 2021 was 140.9 million, accounting for 10.6% of China's population, and this number is expected to reach 164.06 million by 2030. The report also quoted that the country reported ~72.83 million undiagnosed cases of diabetes in 2021. New advancements are specifically designed for wounds with moderate to high exudate levels. In November 2021, Israeli and Chinese researchers developed a smart medical dressing to heal and monitor wounds without suturing. This new method is based on a new antibacterial polymer, structured like a molecular zipper, made from sulfur and nitrogen and releases antibiotics onto the wound area, preventing infection.

Company Profiles

Some of the key players operating in the market include Healthium Medtech Limited, Advanced Medical Solutions Group plc, Essity AB, Corza Medical GmbH, Futura Surgicare Pvt Ltd (Dolphin Sutures), TI Medical, Smith & Nephew Plc, CooperSurgical, Inc, Meril Life Sciences Pvt Ltd, Baxter International Inc, Stryker Corp, 3M Co, Medtronic Plc, Johnson & Johnson, and B Braun SE, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Wound Closure Device Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations.
  • Industry trade journals and other relevant publications.
  • Government documents, statistical databases, and market reports.
  • News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research.
  • Enhance the expertise and market understanding of the analysis team.
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

in the market.

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA